SCHEMBL5862632

SCHEMBL5862632

NC(=O)CCCCCN1c2ccccc2C=Cc2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 5/20 0.56
MTNR1A P48039 1/20 0.51
MTNR1B P49286 1/20 0.51
PTGS1 P23219 4/20 0.50
HTR1A P08908 3/20 0.50
DRD2 P14416 3/20 0.50
HTR2A P28223 3/20 0.50
MAPK1 P28482 2/20 0.50
SLC6A4 P31645 2/20 0.50
HRH1 P35367 2/20 0.50
LMNA P02545 1/20 0.50
TSHR P16473 1/20 0.50
SCN4A P35499 1/20 0.50
SCN5A Q14524 1/20 0.50
SCN9A Q15858 1/20 0.50
CHRM2 P08172 1/20 0.50
ADRA2A P08913 1/20 0.50
CHRM1 P11229 1/20 0.50
ADRA2B P18089 1/20 0.50
ADRA2C P18825 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2143965 0.83 HDAC8 (0.79) HDAC8MTNR1AMTNR1BHDAC3HDAC4
SCHEMBL1366451 0.83 HDAC8 (0.79) HDAC8MTNR1AMTNR1BHDAC3HDAC4
SCHEMBL2143907 0.81 HDAC8 (0.76) HDAC8MTNR1AMTNR1BHDAC3HDAC4
SCHEMBL5464795 0.80 PIM1 (0.59) HDAC8MTNR1AMTNR1BPTGS1HTR1A
SCHEMBL5363710 0.77 MTNR1A (0.58) HDAC8MTNR1AMTNR1BPTGS1HTR1A
SCHEMBL24687436 0.77 HDAC8 (0.69) HDAC8MAPK1KMT2ACYP3A4HDAC3
SCHEMBL608494 0.77 HDAC8 (0.69) HDAC8MAPK1KMT2ACYP3A4HDAC3
SCHEMBL607416 0.77 HDAC8 (0.69) HDAC8MAPK1KMT2ACYP3A4HDAC3
SCHEMBL1366765 0.76 HDAC8 (0.70) HDAC8MTNR1AMTNR1BPTGS1HTR1A
SCHEMBL5323524 0.76 CES1 (0.53) HDAC8MTNR1AMTNR1BPTGS1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7015322-B1 Process for producing carbamazepine DEGUSSA AG (DE) 2006-03-21 US disclosed
EP-0277095-B2 Method for preparing N,N-(dibenzohexatrienylene) ureas NOVARTIS AG (CH) 2001-09-05 EP disclosed
EP-0277095-B1 METHOD FOR PREPARING N,N-(DIBENZOHEXATRIENYLENE) UREAS Novartis AG (CH) 1992-04-01 EP disclosed